Viking Therapeutics Newsroom

Stifel Nicolaus Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)

TipRanksJul 1 09:28 ET

Viking Therapeutics Analyst Ratings

BenzingaJun 27 05:44 ET

Viking Therapeutics Analyst Ratings

BenzingaJun 24 13:05 ET

Viking Therapeutics Analyst Ratings

BenzingaJun 17 11:30 ET

Viking Therapeutics Analyst Ratings

BenzingaJun 4 10:03 ET

Raymond James Upgrades Viking Therapeutics to Strong Buy, Raises Price Target to $116

BenzingaMay 16 14:00 ET

Viking Therapeutics Analyst Ratings

BenzingaMay 16 09:58 ET

Viking Therapeutics (VKTX) Receives a Buy From Truist Financial

TipRanksMay 16 07:40 ET

Viking Therapeutics (VKTX) Gets a Buy From Truist Financial

TipRanksApr 29 07:55 ET

Analysts Conflicted on These Healthcare Names: Viking Therapeutics (VKTX) and Bristol-Myers Squibb (BMY)

TipRanksApr 26 07:45 ET

Buy Rating Affirmed for Viking Therapeutics Amidst Strong Clinical Progress and Strategic Moves

TipRanksApr 26 02:21 ET

Viking Therapeutics Analyst Ratings

BenzingaApr 25 07:23 ET

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)

TipRanksApr 25 06:43 ET

Viking Therapeutics Stock (NASDAQ:VKTX): Analysts Stay Bullish on 2024's Top Mid-Cap

TipRanksApr 5 12:45 ET

Buy Rating Affirmed for Viking Therapeutics Amid Promising Obesity Drug Trials and Strategic Market Positioning

TipRanksMar 29 03:15 ET

Stifel Nicolaus Remains a Buy on Viking Therapeutics (VKTX)

TipRanksMar 27 22:10 ET

Buy Rating Upheld for Viking Therapeutics as VK2735 Shows Promising Clinical Results in Obesity Management

TipRanksMar 27 11:20 ET

Truist Financial Sticks to Their Buy Rating for Viking Therapeutics (VKTX)

TipRanksMar 27 08:41 ET

Viking Therapeutics Analyst Ratings

BenzingaMar 26 12:17 ET

Buy Rating Affirmed for Viking Therapeutics on Strong Phase 1 Results of Weight Loss Candidate VK2735

TipRanksMar 26 11:00 ET